Відео

ua-cam.com/users/shorts7x6G8ivkW2k?si=eG6lzv412AJykc9L

❤❤❤

I will be adding this to my watchlist.

strong buy

3 years ago, lol

Many people said the same thing about Tesla and Elon Musk; look at the company now. Stay Positive on a great product.

Can you do a follow up?

this stock is over

Another jr miner thats has basically lied to their shareholders for three straight years. No one investing here for the same reason no one trusts banks, thus the reason for crypto. If there were a crypto mining company investment would pour in. No one believes their on going bullshit. No investment.

Anything new with WINT. The stock is not doing well

Last three CEO's including Barnholden have been saying the same thing. Three years, three different CEO's with the same basic story, yet the stock continues to lag (or goes down) while gold, silver, copper, zinc continue to rise. Doing something for the common shareholder to develop some trust would go a long way. NO ONE believes in the same old story with the same excuses. Struthers said T mine would be 1000tpd a year and a half ago and we're still probably a year away. Same old jr mining story. Empty promises and dilution.

The snoring in the backround made me laugh 😂

Such promise and yet such nothingness!

I didn't buy enough

Interesting ❤

They have made substantial progress with its signature treatment,Lomecel-B for the treatment of HLHS (Hypoplastic Left Heart Syndrome). The results were very impressive and have the potential to give hope to parents of children with this devastating disease.

😊😊😊😊😊

Amazing 😊

❤❤❤

Theft loss deduction end of year

Looking forward to this company and it's progress. I believe we will see a growth and stronger use in Helium and H3 in the US economy. I thinks this company comes with many advantages especially with there approach to environmental compliance and will adjust to the oncoming changes that we will see in the world.

That PMA study sounds like a big hurdle, might be a bigger challenge than they’re letting on

Need them to talk more about getting Nasdaq compliance back. All of this wont mean shit otherwise

Still not a fan that everything was originally developed for virology, feel like smth is gonna rear its head design wise and cause a problem

Curious to see how the patient enrollment will speed up next couple months.

No known competitors sounds iffy, no way theres just 0 comp

have they shared more on their cost cutting, if theyre doing that stuff properly it could really see them nicely in 2025, but if they’re slashing 2026 could be real tuff

Damn will they have to reverse split soon tho? Surely need to hit that $1 mark asap…

Nice update and all but when do they need to be over a dollar by, might be cutting it close

How long are they gonna b debt free for

Did they even look for a new ceo, how come they went straight internal hire?

So is any1 talking about shares dropping neary 50% the month after this?

A little concerning seeing every comment is from a 2 week old bot account... very suspect. Hopefully its just a lone actor who has a shit ton invested but not a good look at all.

Would anyone invest after watching this?? Are the other execs at this company similar?? GEEZ

Someone messaged me about this company on reddit last week lmao

reduced expenses alot in Q3 - they’re getting smarter I see potential here

They have one person thats the CEO and CFO? never seen that before i dont think

Their near term focus seems to be in the right place, noticed them on webull too which is a green flag

Adding this comp to my watchlist - AEMD right?

First 2 patients is bigg - how many more are expected in 2025??

damn already 3 sites in Australia?? why India tho?

Market cap = cash feels super undervalued if their tech proves out. Might be a decent entry point soon

Big fan of companies with a dual focus. Oncology and pandemic preparedness is forward thinking. Just hope they don’t spread themselves thin.

Zero debt and a solid cash position at almost 7 mill, but will that be enough to push through the trials?

So the hemopurifier isn’t losing any blood components, just targeting the bad stuff. Sounds like a clever design!

PMA approval sounds like a long road ahead, not sure what to think here but open to see progress

They’re the only company focused on extracellular vesicle removal? Looks like it should have more attention around it

The trial timeline for safety data by early 2025 and more detailed data later in the year feels manageable. Hopefully they acc hit these milestones

The Hemopurifier being adaptable for viruses too feels like a solid backup plan. Wonder if they can juggle both oncology and virology efficiently.

Reducing expenses by 7-800k quarter over quarter is solid, but layoffs might signal they’re in tight waters lowkey